Piper Sandler analyst Edward Tenthoff maintained a Hold rating on Seres Therapeutics (MCRB – Research Report) today and set a price target of ...

Seres had $30.8 million in cash and cash equivalents. Based on the Company’s current cash, an anticipated second ...

NASDAQ:MCRB opened at $0.73 on Tuesday. The company has a market capitalization of $126.44 million, a PE ratio of -3.16 and a beta of 2.19. Seres Therapeutics has a 52-week low of $0.54 and a 52 ...

As of late, it has definitely been a great time to be an investor in Seres Therapeutics, Inc. (NASDAQ:MCRB) . The stock has moved higher by 15.2% in the past month, while it is ...

SEC Filings provided by EDGAR Online, Inc.

From its origins in a garage to becoming one of the most recognisable symbols in the world, explore the story behind the iconic Apple logo design. Apple is a company that has changed the technology ...